Summary | China's food and drug authority has approved a
clinical trial of human blood protein yielded from transgenic
rice seeds, which could lead to large-scale production of
much-needed plasma.
clinical trial of human blood protein yielded from transgenic
rice seeds, which could lead to large-scale production of
much-needed plasma.
china.org.cn | 17 May 2017